The Molecular Biology Society of Japan

[1P-0639] Combinational treatment of the p53 activator and the CDK8 inhibitor induces cell death in neuroblastomas

〇Ayana Nakajima1,2, Makoto Miyazaki1,3, Yuko Hibiya1, Arata Tomiyama1,4, Tetsuro Kokubo2, Koichi Ichimura1 (1.Div. Brain Tumor Translational Res., Natl. Cancer Ctr. Res. Inst., 2.Grad. Sch. of Med. Life Sci. Yokohama City Univ., 3.Dept. of Cancer Cell Res., Sasaki Inst., Sasaki Foundation, 4.Dept. Neurosurg. Natl. Def. Med. Col.)

Neuroblastoma, p53, CDK8, Molecular target drug, Cell death

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.